SCA
IDXX icon

SAC Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

SAC Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-78,614
Closed -$4.77M – 487
2014
Q1 		$4.77M Buy
78,614
+60,832
+342% +$3.62M 0.02% 572
2013
Q4 		$946K Buy
17,782
+3,582
+25% +$189K 0.01% 933
2013
Q3 		$708K Buy
+14,200
New +$682K ﹤0.01% 1021

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SAC Capital Advisors's IDXX Position: Q2 2014 in Review

SAC Capital Advisors sold out of Idexx Laboratories (IDXX) in Q2 2014, closing a stake of 78,614 shares — an estimated $4.77M sold.

SAC Capital Advisors first reported a position in IDXX in Q3 2013 and held it in 3 quarters. The position peaked at $4.77M in Q1 2014. 306 funds tracked by Wall St. Rank hold IDXX as of Q2 2014.

  • SAC Capital Advisors reported no remaining Idexx Laboratories position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 78,614 Idexx Laboratories shares in Q2 2014, an estimated $4.77M.
  • SAC Capital Advisors first reported a position in Idexx Laboratories in Q3 2013 and held it in 3 quarters.
  • SAC Capital Advisors's Idexx Laboratories position peaked at $4.77M in Q1 2014.
  • 306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.